Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance

por Palomeras, Sònia, Ruiz-Martínez, Santiago, Puig, Teresa
Publicado 2018

Breast Cancer Stem Cell Culture and Enrichment Using Poly(ε-Caprolactone) Scaffolds

por Palomeras, Sònia, Rabionet, Marc, Ferrer, Inés, Sarrats, Ariadna, Garcia-Romeu, Maria Luisa, Puig, Teresa, Ciurana, Joaquim
Publicado 2016

(−)-Epigallocatechin 3-Gallate Synthetic Analogues Inhibit Fatty Acid Synthase and Show Anticancer Activity in Triple Negative Breast Cancer

por Crous-Masó, Joan, Palomeras, Sònia, Relat, Joana, Camó, Cristina, Martínez-Garza, Úrsula, Planas, Marta, Feliu, Lidia, Puig, Teresa
Publicado 2018

Fatty Acid Synthase Inhibitor G28 Shows Anticancer Activity in EGFR Tyrosine Kinase Inhibitor Resistant Lung Adenocarcinoma Models

por Polonio-Alcalá, Emma, Palomeras, Sònia, Torres-Oteros, Daniel, Relat, Joana, Planas, Marta, Feliu, Lidia, Ciurana, Joaquim, Ruiz-Martínez, Santiago, Puig, Teresa
Publicado 2020

Polycaprolactone Electrospun Scaffolds Produce an Enrichment of Lung Cancer Stem Cells in Sensitive and Resistant EGFRm Lung Adenocarcinoma

por Polonio-Alcalá, Emma, Rabionet, Marc, Ruiz-Martínez, Santiago, Palomeras, Sònia, Porta, Rut, Vásquez-Dongo, Carmen, Bosch-Barrera, Joaquim, Puig, Teresa, Ciurana, Joaquim
Publicado 2021

Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer

por Palomeras, Sònia, Diaz-Lagares, Ángel, Viñas, Gemma, Setien, Fernando, Ferreira, Humberto J., Oliveras, Glòria, Crujeiras, Ana B., Hernández, Alejandro, Lum, David H., Welm, Alana L., Esteller, Manel, Puig, Teresa
Publicado 2019

Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity against Breast Cancer Models Resistant to Anti-HER2 Drugs

por Blancafort, Adriana, Giró-Perafita, Ariadna, Oliveras, Glòria, Palomeras, Sònia, Turrado, Carlos, Campuzano, Òscar, Carrión-Salip, Dolors, Massaguer, Anna, Brugada, Ramon, Palafox, Marta, Gómez-Miragaya, Jorge, González-Suárez, Eva, Puig, Teresa
Publicado 2015

RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer

por Sanz-Moreno, Adrián, Palomeras, Sonia, Pedersen, Kim, Morancho, Beatriz, Pascual, Tomas, Galván, Patricia, Benítez, Sandra, Gomez-Miragaya, Jorge, Ciscar, Marina, Jimenez, Maria, Pernas, Sonia, Petit, Anna, Soler-Monsó, María Teresa, Viñas, Gemma, Alsaleem, Mansour, Rakha, Emad A., Green, Andrew R., Santamaria, Patricia G., Mulder, Celine, Lemeer, Simone, Arribas, Joaquin, Prat, Aleix, Puig, Teresa, Gonzalez-Suarez, Eva
Publicado 2021